1. Home
  2. CHRO vs ICON Comparison

CHRO vs ICON Comparison

Compare CHRO & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • ICON
  • Stock Information
  • Founded
  • CHRO 2002
  • ICON 2023
  • Country
  • CHRO United States
  • ICON Greece
  • Employees
  • CHRO N/A
  • ICON N/A
  • Industry
  • CHRO
  • ICON
  • Sector
  • CHRO
  • ICON
  • Exchange
  • CHRO Nasdaq
  • ICON Nasdaq
  • Market Cap
  • CHRO 3.9M
  • ICON 3.6M
  • IPO Year
  • CHRO 2024
  • ICON 2024
  • Fundamental
  • Price
  • CHRO $0.66
  • ICON $2.14
  • Analyst Decision
  • CHRO Strong Buy
  • ICON Strong Buy
  • Analyst Count
  • CHRO 1
  • ICON 1
  • Target Price
  • CHRO N/A
  • ICON $7.00
  • AVG Volume (30 Days)
  • CHRO 100.6K
  • ICON 12.2K
  • Earning Date
  • CHRO 11-13-2024
  • ICON 11-26-2024
  • Dividend Yield
  • CHRO N/A
  • ICON 3.74%
  • EPS Growth
  • CHRO N/A
  • ICON N/A
  • EPS
  • CHRO N/A
  • ICON 0.35
  • Revenue
  • CHRO N/A
  • ICON $4,810,000.00
  • Revenue This Year
  • CHRO N/A
  • ICON $64.08
  • Revenue Next Year
  • CHRO N/A
  • ICON $100.00
  • P/E Ratio
  • CHRO N/A
  • ICON $6.18
  • Revenue Growth
  • CHRO N/A
  • ICON 5.71
  • 52 Week Low
  • CHRO $0.52
  • ICON $1.81
  • 52 Week High
  • CHRO $6.00
  • ICON $3.85
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 48.22
  • ICON N/A
  • Support Level
  • CHRO $0.63
  • ICON N/A
  • Resistance Level
  • CHRO $0.69
  • ICON N/A
  • Average True Range (ATR)
  • CHRO 0.06
  • ICON 0.00
  • MACD
  • CHRO 0.01
  • ICON 0.00
  • Stochastic Oscillator
  • CHRO 52.55
  • ICON 0.00

About CHRO Chromocell Therapeutics Corporation

Chromocell Therapeutics Corp is a clinical-stage biotechnology company focused on developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain and other associated medical conditions. The company's initial clinical focus is to selectively target the sodium ion-channel known as NaV1.7 for the treatment of various types of chronic neuropathic pain and eye pain. The Company's portfolio also includes pre-clinical work on other sodium channel receptor subtypes, and the company intends to explore these and other compounds for the treatment of additional pain indications.

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.

Share on Social Networks: